deoxycytidine has been researched along with Lymphoma, Large B-Cell, Diffuse in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (32.26) | 29.6817 |
| 2010's | 14 (45.16) | 24.3611 |
| 2020's | 7 (22.58) | 2.80 |
| Authors | Studies |
|---|---|
| Imada, K; Kaneko, H; Mizutani, C; Nagata, O; Naka, R; Tada, K; Tashima, M | 1 |
| Ardeshna, KM; Barton, S; Begum, R; Chau, I; Cunningham, D; Du, Y; Johnson, R; Kühnl, A; Macheta, MP; Paneesha, S; Patel, B; Peckitt, C; Radford, J; Valeri, N; Wotherspoon, A; Zerizer, I | 1 |
| Choi, I; Iwasaki, H; Kada, A; Miyata, Y; Miyazawa, Y; Nagai, H; Saito, A; Yamasaki, S; Yoshida, I | 1 |
| Arora, R; Hildebrandt, GC; Munker, R; Qasrawi, A; Ramlal, R | 1 |
| Cheng, Y; Dang, Q; Huang, J; Shi, W; Yang, L; Zhang, Y; Zhou, H | 1 |
| Cordoba, R; Eyre, TA; Luminari, S | 1 |
| Becker, S; Belhadj, K; Camus, V; Carvalho, M; Cazelles, C; Dupuis, J; El Gnaoui, T; Gaulard, P; Haioun, C; Itti, E; Jardin, F; Le Bras, F; Lemonnier, F; Mounier, N; Poullot, E; Roulin, L; Tilly, H; Vellemans, H; Veresezan, L | 1 |
| Booth, S; Bosworth, J; Browning, JA; Collins, GP; Djebbari, F; Eyre, TA; Hatton, CSR; Hildyard, C; Stanton, L; Vora, SM; Willan, J | 1 |
| Beaussart, P; Bologna, S; Canioni, D; Casasnovas, RO; Castaigne, S; Delarue, R; El Gnaoui, T; Gaulard, P; Haioun, C; Mounier, N; Petrella, T; Rahmouni, A; Salles, G; Sebban, C; Sonet, A; Tilly, H | 1 |
| Colvin, J; Evens, AM; Gordon, LI; Helenowski, I; Kline, J; Larsen, A; Rosen, ST; Smith, SM; van Besien, KM; Winter, JN | 1 |
| Counsell, N; Cunnningham, D; El-Mehidi, N; Fields, PA; Jack, A; Johnson, PW; Linch, DC; Pocock, C; Radford, J; Smith, P; Townsend, W; Webb, A | 1 |
| Dong, M; Gui, L; He, X; Liu, P; Qin, Y; Shi, Y; Yang, J; Yang, S; Zhang, C; Zhou, S | 1 |
| Attygalle, A; Barton, S; Chau, I; Chua, S; Cunningham, D; Dearden, C; Ethell, M; Gleeson, M; Hawkes, EA; Horwich, A; Peckitt, C; Potter, M; Wotherspoon, A | 1 |
| Ahmed, S; Alousi, A; Anderlini, P; Andersson, BS; Bashir, Q; Champlin, R; Dabaja, B; Fanale, M; Gulbis, A; Hagemeister, F; Hosing, C; Jones, RB; Liu, Y; Nieto, Y; Oki, Y; Pinnix, C; Popat, U; Qazilbash, M; Shah, N; Shpall, EJ; Thall, PF; Valdez, BC | 1 |
| Alamoudi, S; Anglin, P; Baetz, T; Chen, BE; Cheung, M; Couban, S; Crump, M; Djurfeldt, MS; Hay, AE; Ismail, WS; Kouroukis, CT; Kuruvilla, J; Luminari, S; MacDonald, DA; Meyer, RM; Olney, HJ; Seftel, M; Shepherd, L; Turner, AR | 1 |
| Aiba, K; Hayashi, K; Homma, S; Ito, M; Kamata, Y; Kan, S; Nagasaki, E | 1 |
| Bae, SH; Baek, JH; Choi, Y; Jo, JC; Joo, YD; Kim, DY; Kim, H; Lee, JH; Lee, JL; Lee, KH; Lee, WS; Ryoo, HM | 1 |
| Liu, YF | 1 |
| Connors, JM; Gascoyne, RD; Hitz, F; Hoskins, P; Klasa, R; Moccia, AA; Power, MM; Savage, KJ; Sehn, LH; Shenkier, T; Shepherd, JD; Slack, GW; Song, KW | 1 |
| Amengual, JE; Gardner, LB; Ibrahim, S; Zhang, X | 1 |
| Cho, GJ; Chung, JS; Joo, YD; Kim, KH; Kim, YS; Lee, WS; Shin, HJ; Shin, SH; Sohn, CH | 1 |
| Cunningham, D; Hawkes, EA; Okines, AF; Plummer, C | 1 |
| Bartlett, N; Beaven, A; Drachman, JG; Forero-Torres, A; Lobuglio, AF; Moskowitz, CH; Myint, H; Nasta, S; Northfelt, DW; Whiting, NC | 1 |
| Archer, CD; Catovsky, D; Chau, I; Cunningham, D; Gill, K; Harries, M; Hill, M; Koh, DM; Norman, AR; Prior, Y; Ross, PJ; Uzzell, M; Wotherspoon, A | 1 |
| Avilés, A; Fernández, R; Huerta-Guzmán, J; Neri, N | 1 |
| Dimopoulos, M; Economopoulos, T; Fountzilas, G; Papageorgiou, ES; Papageorgiou, S; Pavlidis, N; Tsirigotis, P | 1 |
| Capobianco, G; Corazzelli, G; Della Cioppa, P; Marcacci, G; Pinto, A; Russo, F | 1 |
| Arnaud, P; Bordier, V; Couturier, J; Decaudin, D; Lantz, O; Marszak, FB; Martin, A; Mathiot, C; Némati, F; Poupon, MF; Santo, Jd; Vincent-Salomon, A | 1 |
| Chau, I; Chong, G; Cunningham, D; Horwich, A; Last, K; Norman, A; Oates, J; Sirohi, B; Wotherspoon, A | 1 |
| Alarcón, J; Blancas, I; Gutiérrez, A; López, A; Martínez, J; Morey, M; Navarrete, M; Palacios, A; Perelló, A; Rodríguez, J | 1 |
| Dhabhar, B; Hazarika, N; Saikia, TK | 1 |
1 review(s) available for deoxycytidine and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
The use of frailty assessments in treating older adults with aggressive lymphomas.
Topics: Age Factors; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Disease Management; Doxorubicin; Frailty; Gemcitabine; Geriatric Assessment; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Prednisone; Prognosis; Rituximab; Vincristine | 2021 |
14 trial(s) available for deoxycytidine and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Rituximab; Survival Rate | 2020 |
Efficacy of R-GCVP in patients with late relapse of diffuse large B-cell lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisolone; Recurrence; Retrospective Studies; Rituximab; Survival Rate; Vincristine | 2019 |
Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Rituximab; Secondary Prevention; Survival Rate | 2013 |
A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Pyrazines; Recurrence; Treatment Outcome | 2013 |
De novo treatment of diffuse large B-cell lymphoma with rituximab, cyclophosphamide, vincristine, gemcitabine, and prednisolone in patients with cardiac comorbidity: a United Kingdom National Cancer Research Institute trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Gemcitabine; Heart Diseases; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisolone; Rituximab; Severity of Illness Index; Stroke Volume; Treatment Outcome; United Kingdom; Vincristine | 2014 |
Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Deoxycytidine; Drug Administration Schedule; Female; Follow-Up Studies; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Hydroxamic Acids; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Melphalan; Middle Aged; Recurrence; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Vorinostat | 2015 |
Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Deoxycytidine; Dexamethasone; Etoposide; Female; Follow-Up Studies; Gemcitabine; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Prognosis; Recurrence; Salvage Therapy; Survival Analysis; Time Factors; Transplantation, Autologous | 2015 |
Biweekly dose-dense gemcitabine-oxaliplatin and dexamethasone for relapsed/refractory aggressive non-Hodgkin lymphoma: A multicenter, single-arm, phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Female; Gemcitabine; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Remission Induction; Salvage Therapy; Treatment Outcome | 2016 |
[Clinical Efficacy Comparison of Different Second Line Salvage Chemotherapy Regimens for the Treatment of Elderly Patients with Relapsed and Refractory Diffuse Large B Cell Lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dexamethasone; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Prognosis; Remission Induction; Rituximab; Salvage Therapy; Survival Rate; Treatment Outcome | 2016 |
Gemcitabine, etoposide, cisplatin, and dexamethasone in patients with refractory or relapsed non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Deoxycytidine; Dexamethasone; Etoposide; Female; Follow-Up Studies; Gemcitabine; Glucocorticoids; Humans; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Stem Cell Transplantation; Treatment Outcome; Young Adult | 2009 |
Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Follow-Up Studies; Gemcitabine; Hodgkin Disease; Humans; Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Male; Methylprednisolone; Middle Aged; Recurrence; Survival Rate | 2003 |
Gemcitabine and cisplatin in refractory malignant lymphoma.
Topics: Actuarial Analysis; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Gemcitabine; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Pilot Projects; Prospective Studies; Survival Analysis; Treatment Outcome | 2004 |
Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Remission Induction; Salvage Therapy; Survival Analysis; Vinblastine; Vinorelbine | 2005 |
GEMOX-R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large-cell lymphoma: a phase II study.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prognosis; Recurrence; Rituximab; Salvage Therapy; Treatment Outcome | 2008 |
16 other study(ies) available for deoxycytidine and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Effectiveness and safety of R-GCD (rituximab, gemcitabine, carboplatin, and dexamethasone) for transplant-ineligible relapse/refractory diffuse large B-cell lymphoma and grade 3a follicular lymphoma: a retrospective analysis comparing with R-GDP (rituxima
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Dexamethasone; Gemcitabine; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Retrospective Studies; Rituximab; Salvage Therapy | 2022 |
Rituximab-Mediated Complement-Dependent Cytotoxicity Enhanced by Gemcitabine in Older Patients with Previously Rituximab-Treated Diffuse Large B-Cell Lymphoma: Study Protocol.
Topics: Activities of Daily Living; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dexamethasone; Gemcitabine; Humans; Lymphoma, Large B-Cell, Diffuse; Remission Induction; Rituximab; Salvage Therapy; Transplantation, Autologous | 2020 |
Allogenic hematopoietic stem cell transplantation for prolonged bone marrow aplasia after chimeric antigen receptor (CAR) T-cell therapy for relapsed diffuse large B-cell lymphoma.
Topics: Adrenal Cortex Hormones; Allografts; Anemia, Aplastic; Antibodies, Monoclonal, Humanized; Antigens, CD19; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Deoxycytidine; Doxorubicin; Etoposide; Gemcitabine; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy, Adoptive; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Oxaliplatin; Prednisone; Recurrence; Rituximab; Salvage Therapy; Transplantation, Autologous; Vincristine | 2020 |
Ibrutinib resistance in a patient with transformed diffuse large B-cell lymphoma from primary pulmonary mucosa-associated lymphoid tissue lymphoma.
Topics: Adenine; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Cyclophosphamide; Deoxycytidine; Doxorubicin; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Lung Neoplasms; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Oxaliplatin; Piperidines; Prognosis; Rituximab; Vincristine | 2020 |
Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Oxaliplatin; Retrospective Studies; Rituximab; Transplantation, Autologous; Treatment Outcome; Young Adult | 2021 |
[Efficacy and safety evaluation of gemcitabine combined with oxaliplatin in lymphoma patients after failure of multiple chemotherapy regimens].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Remission Induction; Salvage Therapy; Thrombocytopenia; Young Adult | 2014 |
Rituximab, Gemcitabine, Cisplatin and Methylprednisolone (R-GEM-P) is an effective regimen in relapsed diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Drug Administration Schedule; Drug Substitution; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Neutropenia; Recurrence; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Thrombocytopenia; Treatment Outcome | 2015 |
Gemcitabine enhances rituximab-mediated complement-dependent cytotoxicity to B cell lymphoma by CD20 upregulation.
Topics: Antigens, CD20; Azacitidine; Cell Line, Tumor; Complement System Proteins; Cytotoxicity, Immunologic; Deoxycytidine; Gemcitabine; Humans; Lenalidomide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; NF-kappa B; Rituximab; Thalidomide; Up-Regulation | 2016 |
Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dexamethasone; Drug Resistance, Neoplasm; Female; Gemcitabine; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Recurrence; Retreatment; Retrospective Studies; Salvage Therapy; Treatment Outcome; Young Adult | 2017 |
Regression of HIV-related diffuse large B-cell lymphoma in response to antiviral therapy alone.
Topics: Adenine; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Deoxycytidine; Drug Combinations; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Fluconazole; HIV Infections; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Organophosphonates; Oxazines; Positron-Emission Tomography; Radiography; Trimethoprim, Sulfamethoxazole Drug Combination | 2008 |
Cardiotoxicity in patients treated with bevacizumab is potentially reversible.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Capecitabine; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Labeling; Early Termination of Clinical Trials; Epirubicin; Female; Fluorouracil; Heart Failure; Humans; Lymphoma, Large B-Cell, Diffuse; Meta-Analysis as Topic; Paclitaxel; Prednisone; Razoxane; Remission, Spontaneous; Rituximab; Trastuzumab; Vincristine | 2011 |
Pilot study of dacetuzumab in combination with rituximab and gemcitabine for relapsed or refractory diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Pilot Projects; Recurrence; Rituximab; Treatment Outcome | 2013 |
Gemcitabine, ifosfamide, oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a pilot study.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Pilot Projects; Remission Induction; Rituximab; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2006 |
High efficacy of combined rituximab and gemcitabine on Epstein-Barr virus-associated human B-cell lymphoma obtained after Hodgkin's xenograft in immunodeficient mice.
Topics: Adult; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Deoxycytidine; Epstein-Barr Virus Infections; Female; Gemcitabine; Herpesvirus 4, Human; Hodgkin Disease; Homeodomain Proteins; Humans; Immunoglobulin Heavy Chains; Lymph Nodes; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mice; Mice, Knockout; Mice, SCID; Nucleic Acid Hybridization; Rituximab; Sialic Acid Binding Ig-like Lectin 2; Transplantation, Heterologous; Tumor Cells, Cultured | 2006 |
Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL).
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Drug Evaluation; Female; Gemcitabine; Humans; Immunotherapy; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Survival Rate; Treatment Outcome | 2007 |
Highly elevated serum CA 125 in a lady with ascites and retroperitoneal mass--a diagnostic dilemma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Ascites; CA-125 Antigen; Cyclophosphamide; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Paclitaxel; Prednisone; Radiography, Abdominal; Retroperitoneal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2008 |